Whole blood Epstein-Barr virus DNA load as a diagnostic and prognostic surrogate: Extranodal natural killer/T-cell lymphoma

Leukemia and Lymphoma

Volumn 50, Issue 5, 2009, Pages 757-763

  Kim, Hyo Song ^a   Kim, Kyung Hee ^a   Kim, Kyoung Ha ^a   Chang, Myung Hee ^a   Ji, Sang Hoon ^a   Lim, Do Hyoung ^a   Kim, Kihyun ^a   Kim, Seok Jin ^a   Ko, Younghyeh ^a   Ki, Chang Seok ^a   Jo, Sook Jung ^b   Lee, Jae Won ^b   Kim, Won Seog ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Korea University   (South Korea)

Author keywords

Epstein Barr virus (EBV); Lymphoma; Viral load; Whole blood

Indexed keywords

ANTINEOPLASTIC AGENT; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA DETERMINATION; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NK T CELL LYMPHOMA; OVERALL SURVIVAL; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; REFERENCE VALUE; TREATMENT RESPONSE; UPPER GASTROINTESTINAL TRACT; VIRUS DETECTION; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GASTROINTESTINAL TRACT; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOMA, EXTRANODAL NK-T-CELL; MALE; MIDDLE AGED; PROGNOSIS; SEVERITY OF ILLNESS INDEX; VIRAL LOAD; YOUNG ADULT;

EID: 68449086271     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190902803669     Document Type: Article

References (26)

1. Au WY, Pang A, Choy C, Chim CS, Kwong YL. Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBVpositive lymphomas in immunocompetent patients. Blood 2004;104:243-249.
2. Lei KI, Chan LY, Chan WY, Johnson PJ, Lo YM. Diagnostic and prognostic implications of circulating cell-free Epstein- Barr virus DNA in natural killer/T-cell lymphoma. Clin Cancer Res 2002;8:29-34.
3. Incomserb P, Bhattarakosol P, Kulwichit W, Chantratita W, Hansasuta P. Establishment of real-time polymerase chain reaction-based assay for quantitation of Epstein-Barr virus DNA in healthy donors and in patients with EBV associated lymphoma. J Med Assoc Thai 2005;88(Suppl 4): S280-S286.
4. Park S, Lee J, Ko YH, Han A, Jun HJ, Lee SC, et al. The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood 2007;110:972-978.
5. Kwon JM, Park YH, Kang JH, Kim K, Ko YH, Ryoo BY, et al. The effect of Epstein-Barr virus status on clinical outcome in Hodgkin's lymphoma. Ann Hematol 2006;85:463-468.
6. Ishii H, Ogino T, Berger C, Kochli-Schmitz N, Nagato T, Takahara M, et al. Clinical usefulness of serum EBV DNA levels of BamHI W and LMP1 for Nasal NK/T-cell lymphoma. J Med Virol 2007;79:562-572.
7. Chan AT, Lo YM, Zee B, Chan LY, Ma BB, Leung SF, et al. Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma. J Natl Cancer Inst 2002;94:1614-1619.
8. Lin JC, Wang WY, Chen KY, Wei YH, Liang WM, Jan JS, et al. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med 2004;350:2461-2470.
9. Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999;17:1244.
10. Lee J, Suh C, Park YH, Ko YH, Bang SM, Lee JH, et al. Extranodal natural killer T-cell lymphoma, nasal-type: A prognostic model from a retrospective multicenter study. J Clin Oncol 2006;24:612-618.
11. Lee J, Park YH, Kim WS, Lee SS, Ryoo BY, Yang SH, et al. Extranodal nasal type NK/T-cell lymphoma: Elucidating clinical prognostic factors for risk-based stratification of therapy. Eur J Cancer 2005;41:1402-1408.
12. Lin JC, Chen KY, Wang WY, Jan JS, Liang WM, Tsai CS, et al. Detection of Epstein-Barr virus DNA the peripheralblood cells of patients with nasopharyngeal carcinoma: Relationship to distant metastasis and survival. J Clin Oncol 2001;19:2607-2615.
13. Leung E, Shenton BK, Jackson G, Gould FK, Yap C, Talbot D. Use of real-time PCR to measure Epstein-Barr virus genomes in whole blood. J Immunol Methods 2002;270: 259-267.
14. Wagner HJ, Fischer L, Jabs WJ, Holbe M, Pethig K, Bucsky P. Longitudinal analysis of Epstein-Barr viral load in plasma and peripheral blood mononuclear cells of transplanted patients by real-time polymerase chain reaction. Transplantation 2002; 74:656-664.
15. Frias C, Lauzurica R, Bayes B, Ausina V. Prospective followup of Epstein-Barr virus load in adult kidney transplant recipients by semiquantitative polymerase chain reaction in blood and saliva samples. Eur J Clin Microbiol Infect Dis 2001;20:892-895.
16. Kojima M, Motoori T, Itoh H, Shimizu K, Iijima M, Tamaki Y, et al. Distribution of Epstein-Barr virus in systemic rheumatic disease (rheumatoid arthritis, systemic lupus erythematosus, dermatomyositis) with associated lymphadenopathy: A study of 49 cases. Int J Surg Pathol 2005;13: 273-278.
17. Schifter T, Lewinski UH. Adult onset Still's disease associated with Epstein-Barr virus infection in a 66-year-old woman. Scand J Rheumatol 1998;27:458-460.
18. Moon UY, Park SJ, Oh ST, KimWU, Park SH, Lee SH, et al. Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood. Arthritis Res Ther 2004;6:R295-R302.
19. Lu JJ, Chen DY, Hsieh CW, Lan JL, Lin FJ, Lin SH. Association of Epstein-Barr virus infection with systemic lupus erythematosus in Taiwan. Lupus 2007;16:168-175.
20. Lei KI, Chan LY, Chan WY, Johnson PJ, Lo YM. Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies. Br J Haematol 2000;111:239-246.
21. Fafi-Kremer S, Brengel-Pesce K, Bargues G, Bourgeat MJ, Genoulaz O, Seigneurin JM, et al. Assessment of automated DNA extraction coupled with real-time PCR for measuring Epstein-Barr virus load in whole blood, peripheral mononuclear cells and plasma. J Clin Virol 2004;30:157-164.
22. Wagner HJ, Jabs W, Smets F, Wessel M, Fischer L, Offner G, et al. Real-time polymerase chain reaction (RQ-PCR) for the monitoring of Epstein-Barr virus (EBV) load in peripheral blood mononuclear cells. Klin Padiatr 2000;212:206-210.
23. Stevens SJ, Pronk I, Middeldorp JM. Toward standardization of Epstein-Barr virus DNA load monitoring: Unfractionated whole blood as preferred clinical specimen. J Clin Microbiol 2001;39:1211-1216.
24. Wadowsky RM, Laus S, Green M, Webber SA, Rowe D. Measurement of Epstein-Barr virus DNA loads in whole blood and plasma by TaqMan PCR and in peripheral blood lymphocytes by competitive PCR. J Clin Microbiol 2003; 41:5245-5249.
25. Yang J, Tao Q, Flinn IW, Murray PG, Post LE, Ma H, et al. Characterization of Epstein-Barr virus-infected B cells in patients with post-transplantation lymphoproliferative disease: Disappearance after rituximab therapy does not predict clinical response. Blood 2000;96:4055-4063.
26. Gallagher A, Armstrong AA, MacKenzie J, Shield L, Khan G, Lake A, et al. Detection of Epstein-Barr virus (EBV) genomes in the serum of patients with EBV-associated Hodgkin's disease. Int J Cancer 1999;84:442-448.